| BRXUX | VTIAX | BRXUX / VTIAX | |
| Total Expense Ratio | 0.52 | 0.09 | 578% |
| Annual Report Gross Expense Ratio | 0.52 | 0.09 | 578% |
| Fund Existence | 10 years | 15 years | - |
| Gain YTD | 34.416 | 28.912 | 119% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 3000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.43B | 558B | 0% |
| Annual Yield % from dividends | 2.51 | 2.69 | 93% |
| Returns for 1 year | 33.69 | 27.98 | 120% |
| Returns for 3 years | 69.02 | 49.10 | 141% |
| Returns for 5 years | 60.94 | 32.57 | 187% |
| Returns for 10 years | 114.97 | 78.16 | 147% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| SSEAX | 12.32 | 0.03 | +0.24% |
| SEI Screened World Equity Ex-US A (SIIT) | |||
| BRWAX | 27.68 | 0.01 | +0.04% |
| MFS Blended Research Growth Eq A | |||
| SGPSX | 85.75 | -0.13 | -0.15% |
| ProFunds Small Cap Growth Svc | |||
| JFNCX | 67.74 | -0.17 | -0.25% |
| Janus Henderson Global Life Sciences C | |||
| CZMSX | 15.63 | -0.04 | -0.26% |
| Multi-Manager Small Cap Eq Strat Inst | |||